The Priority Review

Clinical trials Brief

Alexion posts results of Phase 3 ravulizumab trial in HSCT-TMA

The study enrolled 148 participants and completed primary data collection on September 19, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.

Primary source

ClinicalTrials.gov results record, November 4, 2026

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Read the source: Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant clinicaltrials.gov

Machine-summarized from the source above; not independently reported. How we use automation